BPC-157 + TB-500 blend
Also known as: Wolverine stack · Wolverine blend · BPC-157/TB-500 blend · Recovery Blend · BPC + TB
Updated 36 sources
Quick facts
- Half-life
- No value for the blend. BPC-157 clears in under 30 minutes in rats and dogs. The TB-500 fragment has no human value; full-length thymosin beta-4 by IV lasted longer at higher doses.
- Routes
- Subcutaneous injection
- Forms
- Vial (powder)
- Reported dose ranges
- 250 to 1,500 mcg (subcutaneous injection)
- 0.5 to 2 mg (subcutaneous injection)
- Vial sizes
- 10 mg, 20 mg
- FDA status
- Not FDA approved
- WADA
- Prohibited
- In each vial
- BPC-157 5 mg + TB-500 5 mg
What people use BPC-157 + TB-500 blend for
- Tendon and ligament injuries: Achilles, elbow, rotator cuff
- Muscle strains and joint pain
- Recovery after surgery
- Chronic or slow-healing injuries
- Gut repair is mainly the BPC-157 side; TB-500 is added for soft tissue
How it is thought to work. BPC-157, a 15 amino acid gastric peptide fragment, is linked in animals to local repair and blood vessel growth. TB-500, the 7 amino acid thymosin beta-4 fragment Ac-LKKTETQ, is linked to cell migration across the body. Some sellers ship full-length thymosin beta-4 under the TB-500 label.
BPC-157 + TB-500 blend dosing
Injected8
Standard (premixed blend, most common)
Acute injury (premixed blend)
Titration (premixed blend)
Titration (3 steps) and details
Loading…
Optional loading (premixed blend)
Titration (2 steps) and details
Loading…
Low, weekdays (premixed blend)
Timing and details
Loading…
Low to moderate (premixed blend)
Timing and details
Loading…
Wide range (premixed blend)
Doses shown are what sources report, labelled by origin. Not medical advice.
Full BPC-157 + TB-500 blend dosage guideEvery titration step in syringe units, missed doses and how to mix.Vial strengths and syringe units
| Water | Strength | 500 mcgtotal blend, units | 1,000 mcgtotal blend, units | 1,500 mcgtotal blend, units |
|---|---|---|---|---|
| 10 mg vial | ||||
| 1 mLCompetitor guide | 10 mg/mL | 50.05 mL | 100.1 mL | 150.15 mL |
| 2 mLCompetitor guide | 5 mg/mL | 100.1 mL | 200.2 mL | 300.3 mL |
| 3 mLCompetitor guide | 3.333 mg/mL | 150.15 mL | 300.3 mL | 450.45 mL |
| 20 mg vial | ||||
| 2 mLCompetitor guide | 10 mg/mL | 50.05 mL | 100.1 mL | 150.15 mL |
| 3 mLCompetitor guide | 6.667 mg/mL | 7.50.075 mL | 150.15 mL | 22.50.225 mL |
| Component | Per vial | 500 mcg total blend | 1,000 mcg total blend | 1,500 mcg total blend |
|---|---|---|---|---|
| BPC-157 | 5 mg | 250 mcg | 500 mcg | 750 mcg |
| TB-500 | 5 mg | 250 mcg | 500 mcg | 750 mcg |
Doses shown are what sources report, labelled by origin. Not medical advice.
Calculate with this peptideYour vial, your water, your dose: BPC-157 + TB-500 blend in syringe units, with the math shown.What people report
Community-reportedFrom 900 Reddit posts and comments, last mined Oct 23, 2026r/Peptides, r/Biohackers, r/Peptidesource, r/PeptideDiscussion
Doses people report for BPC-157 + TB-500 blend
Injury recovery45 mentions
| Reported | Mentions |
|---|---|
| 500 mcg | 19 |
| 250 mcg | 9 |
| 1 mg | 3 |
| 600 mcg | 3 |
| 2 mg | 2 |
Goal not stated33 mentions
| Reported | Mentions |
|---|---|
| 500 mcg | 10 |
| 250 mcg | 6 |
| 0.5 mg | 4 |
| 2.5 mg | 3 |
Left out: 2 mentions given in syringe units, which mean different doses in different mixes.
How often
| Reported | Mentions |
|---|---|
| Once a day | 39 |
| Twice a day | 10 |
| 5 days on, 2 off | 6 |
| As needed | 3 |
| Every other day | 2 |
Most mentioned alongside
Side effects people mention
Fatigue6 mentions
Hives4 mentions
Most common fix: stop taking it (2)
Itching3 mentions
Insomnia3 mentions
Nausea3 mentions
Lightheadedness2 mentions
Doses shown are what sources report, labelled by origin. Not medical advice.
BPC-157 + TB-500 blend side effects
Reported by users and guides6
From community reports and dosing guides. Not measured rates.
Injection-site redness, itch, bump or sting
Called normal and common
How people manage it
- Rotate sites
Brief light-headedness right after injecting
First days
How people manage it
- Inject seated
Nausea
Uncommon at 500 mcg a day of BPC-157 or less, more likely above; 30 to 60 minutes after the shot
How people manage it
- Drop to about 300 mcg of BPC-157
Fatigue or lethargy during TB-500 loading
Uncommon, weeks 1 to 2
How people manage it
- Inject in the evening
Mild headache
Occasional
How people manage it
- Hydrate
Flu-like feeling
Rare, 24 to 48 hours after the first loading shot
Who should avoid it
Active cancer or undiagnosed lumpsCondition
Guides flag a concern from blood vessel growth.
PregnancyCondition
Listed as a reason to avoid by guides.
Tested sportCondition
Both parts are prohibited by WADA at all times.
KLOWSubstance
KLOW already contains BPC-157 and TB-500, so running both doubles them.
Storage
Powder (before mixing)
- Temperature
- -20 °C
Freezer at -20 C for long-term storage. Room temperature is fine for shipping.
Mixed vial
- Temperature
- 2 to 8 °C
- Use within
- 28 days
Fridge at 2 to 8 C, never frozen. Guides say 28 days or about 30; one gives BPC-157 21 to 28 days and TB-500 21 days. The 28 days comes from the bacteriostatic water preservative, not a blend stability study.
Mixed with: Bacteriostatic water
Mixing. Check whether the label mg is per peptide or the total; 10 mg usually means 5 + 5. Run as separate vials, BPC-157 (5 or 10 mg) usually gets 2 mL and TB-500 (5 or 10 mg) 1 to 2 mL. BPC-157 mixes clear; TB-500 clear or very faintly tinted.
Stacks people report
Adding GHK-Cu turns it into GLOW; adding GHK-Cu and KPV makes KLOW. Do not run Wolverine alongside KLOW, which doubles up the BPC-157 and TB-500.
Growth hormone secretagogues like CJC-1295 with ipamorelin, plus HGH or PEG-MGF, are listed as common partners.
Compare BPC-157 + TB-500 blend
Evidence and legal status
Evidence: no human trials
Very limited. One retrospective knee-injection chart review: of 16 patients reached, 12 got BPC-157 alone (11 improved) and 4 got BPC-157 plus thymosin beta-4 (3 of 4 improved), with no control group. A 2025 review recounts it as 7 of 12 with relief over 6 months. The rest is animal work on each peptide separately.
FDA and WADA
An approval withdrawn, or removed from FDA's compounding lists.
Neither part is FDA approved. On April 22, 2026 FDA removed BPC-157 and the TB-500 fragment from 503A Category 2 because nominations were withdrawn. In July 2026 an advisory committee recommended both for the 503A bulks list (reported 8 to 6), against staff advice. Non-binding; rulemaking is required.
WADA 2026 names BPC-157 under S0 and thymosin beta-4 and its derivatives, such as TB-500, under S2.3. Both are prohibited at all times. One guide reports an FDA warning letter to a peptide seller dated 2026-08-24, not verified on fda.gov.
WADA: Prohibited
BPC-157 + TB-500 blend questions
Does 10 mg mean each or both?
Usually both: 5 mg BPC-157 plus 5 mg TB-500. A 20 mg vial is 10 + 10. Check the label.
How many units is 1,000 mcg?
On a 20 mg vial with 2 mL, 10 units on a U-100 syringe, which is 500 mcg of each peptide.
How much water for a 20 mg vial?
2 mL is the most common.
What is the typical daily dose?
About 1,000 mcg of blend, so 500 mcg of each peptide.
Blend or separate vials?
Separate vials if you want a TB-500 loading phase or BPC-157 near the injury with TB-500 in the belly. The blend means one shot and a fixed ratio.
How do people run it as separate vials?
The common center is BPC-157 250 to 500 mcg daily plus TB-500 2 to 2.5 mg twice weekly, for 4 to 8 weeks. Published plans range from TB-500 at 1.25 mg twice weekly to 2.5 mg daily, and BPC-157 from 250 mcg to 1 mg a day. Maintenance usually drops TB-500 to once a week.
What about specific injuries?
One guide uses: tendon or ligament, BPC-157 500 mcg a day within 2 cm of the injury plus TB-500 2.5 mg twice weekly then weekly, 8 to 12 weeks; muscle, BPC-157 250 to 500 mcg plus TB-500 2 mg twice weekly, 4 to 6 weeks; joint, BPC-157 500 mcg plus TB-500 2.5 to 5 mg twice weekly, 12+ weeks; post-surgery, BPC-157 500 mcg plus TB-500 5 mg twice weekly after surgeon clearance.
What do forum users run?
Forums run TB-500 higher than guides. One moderator's standard is BPC-157 250 to 500 mcg a day near the injury for 8 to 12 weeks plus TB-500 10 mg a week in two shots for 4 to 6 weeks, then 5 mg weekly. Another user ran BPC-157 500 mcg daily for 2 weeks then every other day, with TB-500 2.5 mg twice weekly for 2 weeks then weekly.
Does a 1:1 blend over- or under-dose TB-500?
Guides disagree because they benchmark against different separate-vial schedules. At 500 mcg of BPC-157 a day a 1:1 blend gives about 3.5 mg TB-500 a week. One guide calls that too much, another too little. A third warns the reverse trap: using a TB-500 chart on a blend vial means a 2.5 mg draw carries about 1.25 mg BPC-157, five times the usual 250 mcg.
Can both go in the same syringe?
Sources disagree. Some say yes, others say keep them separate.
How long until it works?
Guides say 2 to 3 weeks for acute injuries and 4 to 8 weeks for chronic ones. No trial has measured this.
How long should a cycle be?
Guides give 4 to 6 weeks, 6 to 8 weeks, or 8 to 12 weeks on with 2 to 4 weeks off. No human data go past 8 weeks. To finish, taper TB-500 first (weekly for 2 weeks), then BPC-157 (125 to 250 mcg or every other day), then stop. A gentler start: BPC-157 250 mcg a day plus TB-500 1 mg twice weekly in week 1.
Do I need to inject near the injury?
It is common for BPC-157, usually with TB-500 in the belly. The animal PK data do not require it.
Is it better than either alone?
Not demonstrated. No human study has compared the pair with either peptide on its own.
Who should skip it?
Guides list active cancer or undiagnosed lumps, pregnancy and tested sport.
Is it banned in sport or FDA approved?
Banned by WADA at all times. Neither part is FDA approved.
Ask about BPC-157 + TB-500 blend
Answers come from this site's pages only, with a link to each source.
Sources
36 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study4
- He L et al. 2022, pharmacokinetics of BPC-157 in rats and dogs, Front PharmacolPubMed · checked Oct 23, 2026
- Ruff D et al. 2010, IV thymosin beta 4 in healthy volunteers, Ann N Y Acad SciPubMed · checked Oct 23, 2026
- Lee E, Padgett B 2021, intra-articular BPC 157 for knee painPubMed · checked Oct 23, 2026
Regulatory9
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (updated April 22, 2026)FDA (Internet Archive copy) · checked Oct 24, 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksFDA · checked Oct 24, 2026
- July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory CommitteeFDA · checked Oct 24, 2026
Competitor guide20
- BPC-157 + TB-500 10 mg blend protocolpeptidedosages.com · checked Oct 23, 2026
- BPC-157 + TB-500 blendpeptidedosages.com · checked Oct 23, 2026
- Wolverine stack dosage chartpeptidedeck.com · checked Oct 23, 2026
Community-reported3
- BPC-157 and how to stackelitefitness.com forum · checked Oct 23, 2026
- BPC-157 for sore jointselitefitness.com forum · checked Oct 23, 2026
- GLOW stack post surgeryT Nation forum · checked Oct 23, 2026